Antibodies News and Research

RSS

Study reveals how light-activated macrophages increase their appetite for cancer cells

The body has a veritable army constantly on guard to keep us safe from microscopic threats from infections to cancer.

12 Aug 2024

New diagnostic method enhances early detection of pancreatic cancer

Pancreatic cancer is one of the most lethal forms of cancer, primarily because it is usually diagnosed very late.

9 Aug 2024

Cross-reactive T cells link SARS-CoV-2 to autoimmune triggers in MIS-C

Research identifies cross-reactive T cells targeting both SARS-CoV-2 and human SNX8 protein, providing insights into the autoimmune mechanisms driving MIS-C in children.

8 Aug 2024

New insights into the role of cancer-associated fibroblasts in promoting lymphatic metastasis

Lymph node metastasis is a crucial factor in cancer progression, significantly affecting patient prognosis and treatment outcomes.

8 Aug 2024

Saliva test outperforms blood test in indicating the severity of recurrent respiratory infections in children

A saliva test can more accurately indicate the severity of recurrent respiratory infections in children than the standard blood test.

8 Aug 2024

Amyloid immunotherapy for early Alzheimer's: Promising but fraught with challenges

Researchers highlighted the complexities of using amyloid immunotherapy for early Alzheimer's disease, discussing its clinical benefits, challenges, and broader health implications. Despite some positive results, concerns over adverse effects, trial biases, and cost hinder widespread adoption.

7 Aug 2024

Investigational drug shows promise in treating rare blood disease in fetuses

Data from a new investigational drug that could alter the standard treatment for a rare blood disease suggests it has the potential to delay or prevent anemia and the need for intrauterine blood transfusions in babies who are at high risk for the condition, known as Hemolytic Disease of the Fetus and Newborn (HDFN).

7 Aug 2024

Research reveals autoimmune mechanism behind multisystem inflammatory syndrome in children

Study reveals a mechanism behind multisystem inflammatory syndrome in children (MIS-C).

7 Aug 2024

Innovative nasal spray and vaccine for respiratory virus protection

A team of researchers, led by the University of Houston, has discovered two new ways of preventing and treating respiratory viruses.

6 Aug 2024

FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment

On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.

From Sino Biological Inc. 5 Aug 2024

FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer

On June 14, 2024, the U.S. FDA approved AstraZeneca's Durvalumab (IMFINZI®) for primary advanced or recurrent endometrial cancer with mismatch repair deficiency. Endometrial cancer is the most prevalent gynecologic cancer, with an estimated 66,200 new U.S. cases in 2023.

From Sino Biological Inc. 5 Aug 2024

H5N1 avian flu found in Texas dairy cattle and milk, sparking concerns about underreported infections

Researchers at UTMB found H5N1 avian influenza virus in Texas dairy cattle and milk, highlighting potential underreporting of infections among farm workers and the need for better surveillance.

4 Aug 2024

Study finds fourfold increase in risk of overt hypothyroidism after diagnosis of gestational subclinical hypothyroidism

A new study has shown that subclinical hypothyroidism diagnosed before 21 weeks of pregnancy is associated with more than fourfold higher rates of overt hypothyroidism or thyroid replacement therapy within 5 years of delivery.

2 Aug 2024

Study reveals new H5N1 variants evade human antibodies more effectively

In a new study led by UNC Charlotte researchers from the Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) and the North Carolina Research Campus at Kannapolis, University scholars have found evidence that the latest variants of H5N1 influenza -; commonly known as avian or bird flu -; are better at evading antibodies, including those of humans, than previous iterations of the virus.

2 Aug 2024

Closing the gap: UNICEF and WHO call for improved breastfeeding support

In the last 12 years, the number of infants under six months of age globally who are exclusively breastfed has increased by more than 10%.

1 Aug 2024

Targeting 14 modifiable risk factors from childhood to old age could prevent or delay dementia

Addressing 14 modifiable risk factors, starting in childhood and continuing throughout life, could prevent or delay nearly half of dementia cases, even as people around the world live longer and the number of people with dementia is set to rise dramatically in all countries, according to the third Lancet Commission on dementia prevention, intervention, and care, which is being presented at the Alzheimer's Association International Conference (AAIC 2024).

1 Aug 2024

Powerful visualization technologies offer new insight into understanding muscle contraction in humans

The connections between the nervous system and muscles develop differently across the kingdom of life.

31 Jul 2024

Bird flu cases are going undetected, new study suggests. It’s a problem for all of us.

A new study lends weight to fears that more livestock workers have gotten the bird flu than has been reported.

31 Jul 2024

Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics

WOBURN, Mass.–(BUSINESS WIRE)–Spear Bio Inc., a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, announced the successful closing of its $45 million Series A financing.

From Spear Bio 31 Jul 2024

Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its fourth generation CHO Edge System.

From Asimov 31 Jul 2024

Antibodies News and Research

Study reveals how light-activated macrophages increase their appetite for cancer cells

New diagnostic method enhances early detection of pancreatic cancer

Cross-reactive T cells link SARS-CoV-2 to autoimmune triggers in MIS-C

New insights into the role of cancer-associated fibroblasts in promoting lymphatic metastasis

Saliva test outperforms blood test in indicating the severity of recurrent respiratory infections in children

Amyloid immunotherapy for early Alzheimer's: Promising but fraught with challenges

Investigational drug shows promise in treating rare blood disease in fetuses

Research reveals autoimmune mechanism behind multisystem inflammatory syndrome in children

Innovative nasal spray and vaccine for respiratory virus protection

FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment

FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer

H5N1 avian flu found in Texas dairy cattle and milk, sparking concerns about underreported infections

Study finds fourfold increase in risk of overt hypothyroidism after diagnosis of gestational subclinical hypothyroidism

Study reveals new H5N1 variants evade human antibodies more effectively

Closing the gap: UNICEF and WHO call for improved breastfeeding support

Targeting 14 modifiable risk factors from childhood to old age could prevent or delay dementia

Powerful visualization technologies offer new insight into understanding muscle contraction in humans

Bird flu cases are going undetected, new study suggests. It’s a problem for all of us.

Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics

Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee

Immunology eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News